Cool advances in minimally invasive tumor treatment with subQ cryotherapy

This presentation will begin with a brief overview of the century’s long history and use of cold therapy for treatment of diseases and tumors. We'll then discuss the principles of minimally-invasive cryoablation, the mechanism of ice formation within tissues, and its modern veterinary applications, especially highlighting its dermal and subcutaneous use for tumor ablation. Several histological diagnoses and anatomical locations will be reviewed with case reports of several patients. We will discuss how carbon-dioxide powered cryoablation can be integrated into a comprehensive cancer treatment plan. Finally, we’ll explore cryoablation’s potential to trigger the immune system.

Learning Outcomes
● Recognize subcutaneous cryoablation is an efficacious tumor treatment modality for veterinary patients ● Understand how freeze-thaw cycles cause damage and necrosis to tumor cells and microvasculature ● Realize that cryoablation is minimally-invasive and does not require general anesthesia nor large incision healing ● Identify that adaptive immune system can be triggered by tumor necrosis which can lead to in situ vaccine and potentially abscopal effect.

Speakers
Bailey Surtees, Inventor and CEO - Kubanda Cryotherapy

Presented at London Vet Show 2024
15 Nov 2024 09:00 - 09:50 Exhibitor Showcase Theatre 3

Please note this session is not RACE-approved but you can still earn a CPD certificate